The largest database of trusted experimental protocols

11 protocols using cd3 clone 2gv6

1

Comprehensive Immunohistochemical Characterization of Salivary Gland Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin-fixed, paraffin-embedded labial and parotid salivary gland tissue samples were serially sectioned at 3 µm thickness and deparaffinized. Automatic staining was performed with H&E, and tissue samples were manually stained for CD3 (clone 2GV6, Roche), high-molecular-weight cytokeratin (hmwCK, clone 34βE12, Roche) and CD20 (clone L-26, Roche). Antigen retrieval was performed for 15 min in EDTA buffer (98°C, pH 8.0), and endogenous peroxidase was blocked. Pre-fixed dilutions of primary antibodies (1% BSA-PBS, Roche) were applied for 75 min. Primary antibodies were visualized by using 3,3′-diaminobenzidine (DAB) after incubation with a poly-horseradish peroxidase-labelled secondary antibody (Thermo Scientific). Tonsillar tissue was used as both a positive and negative control, as the tonsillar epithelium expresses hmwCK and does not express CD3 or CD20, and the tonsillar lymphoid tissue expresses CD3 and CD20 but does not express hmwCK.
+ Open protocol
+ Expand
2

Comprehensive Immunophenotyping of Tissue Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
We performed immunohistochemical stains on formalin-fixed paraffin-embedded three micron tissue sections using an automated immunostainer Benchmark Ultra (Roche) with an Ultra-View Universal DAB brown detection kit (alongside an Ultra-View Universal AP Red detection kit for double staining). These antibodies were used for the following targets: CD3 (clone 2GV6, predilute Roche Cat # 790-4341), CD4 (clone SP35, predilute Roche Cat# 790-4423), CD8 (clone SP57, predilute Roche Cat#790-4460), granzyme B (clone GrB-7+D170, dilution 1:100, Millipore Cat# MAB 3070), perforin (clone KM585 PI-8) (dilution 1:200, Leica Cat# NCL-L-perforin) detection with Optiview kit (Roche), CD68 (clone KP1, predilute Roche Cat#790-2931), CD163 (clone MRQ-26, predilute Roche Cat#760-4437).
+ Open protocol
+ Expand
3

Monoclonal Antibody Characterization for IHC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal antibody (mAb) HCA2, which recognizes β2m-free HLA-A (excluding -A24), -B7301 and -G heavy chains [23 (link)], and mAb HC10, which recognizes β2m-free HLA-A3, -A10, -A28, -A29, -A30, -A31, -A32, -A33 and all β2m-free -HLA-B (excluding -B5702, -B5804 and -B73) and -HLA-C heavy chains [24 (link), 25 (link)], were developed and characterized as previously described. mAbs were purified from ascitic fluid by affinity chromatography on Protein G columns. The purity and specific reactivity of mAb preparations were assessed by SDS-PAGE, binding assays and western blotting, respectively. A pool of mAb HCA2 and HC10 (ratio: 1:1) was used for immunohistochemistry (IHC) of tissues sections.
The IFNAR1- (ab62693, Abcam), CD3- (clone 2GV6, Ventana, Roche), CD8- (clone C8/144b, Dako), and PD-L1- (clone 22C3 pharmDx, Dako) specific mAbs were purchased from the indicated companies.
+ Open protocol
+ Expand
4

Comprehensive Immunohistochemical Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry (IHC) was performed on 4 µm thin FFPE tissue sections as previously described [29 (link)], using automated slide stainers BenchMark (Ventana Medical System-Roche) and Leica Bond-III, (Leica Biosystems,), according to manufacturer’s instructions. To characterize lymphocytic infiltrate, CD3 (clone 2GV6, ready to use), CD4 (clone SP35, ready to use), and CD8 (clone SP57, ready to use) monoclonal antibodies (Roche) were applied on tissue sections for 15 min at 25 °C. Monoclonal antibody directed to nuclear transcription factor forkhead box P3 (FOXP3) (clone D2W8E, 1:250, Cell Signaling Technology) was utilized to identify regulatory T cells. CD68 (clone KP-1, ready to use, Roche), and CD163 (clone MRQ-26, Roche) monoclonal antibodies were employed to identify macrophages and M-2 like macrophages, respectively [33 (link)]. Intra-tumoral vascularization was assessed by using CD31 monoclonal antibody (clone JC70A, ready to use, Dako). Sections were counterstained with hematoxylin.
+ Open protocol
+ Expand
5

Quantitative Renal Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three μm-thick sections were cut from 1 core formalin-fixed and paraffin-embedded tissue of a 16-gauge needle biopsy and stained using antibodies against CD3 (clone 2GV6, Roche), CD4 (clone SP35, Roche), CD8 (clone SP57, Roche), CD20 (clone L26, Roche), CD68 (clone PGM1, Diagnostic Biosystems), CD56 (clone MRQ42, Roche), CD138 (clone B-A38, Roche) and TIA1 (2G9A10F5, Vitro Máster Diagnóstica). Here, TIA1 marker was used as a surrogate marker of cytotoxic T and NK cell granules. 39 39. Tian, Q. Immunostains were automatically performed with a Benchmark XT (Roche) and revealed with DAB Optiview Kit (clone B-A38, Roche). Stained inflammatory cells were quantitatively assessed by 2 pathologists blinded to clinical background under light microscopy in the glomerular capillaries, peritubular capillaries, and interstitial compartment, especially when forming aggregates in scarred areas. A standardized evaluation of the cell count in renal parenchyma was conducted according to renal compartments. In glomerular capillaries, cell count was standardized by dividing the number of cells by the total glomeruli. In peritubular capillaries and renal interstitial compartments, cell count was standardized by dividing the number of cells by the length of the sample in millimeters.
+ Open protocol
+ Expand
6

Immunohistochemical Profiling of Ovarian Carcinoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Briefly, for immunohistochemistry, 4 μm sections were cut from the formalin-fixed paraffin embedded (FFPE) blocks of the cancer patient collected at the time of cytoreductive surgery and 79 additional high grade serous ovarian carcinoma from a recently described tissue microarray ovarian cancer cohort (15 (link)), and stained with the following antibodies according to the manufacturers’ instructions. CD8 (clone 144B, ready to use, DAKO, Carpinteria, CA), CD4 (clone 1F6, 1:40 dilution, Vector, Burlingame CA), CD3 (clone 2GV6, Ventana, Tucson, AZ), CD56 (clone 1B6, 1:200 dilution, Vector, Burlingame CA), CD68 (clone PG-M1, ready to use, DAKO, Carpinteria, CA), CD20 (clone L26, 1:200 dilution, DAKO, Carpinteria, CA), TIA-1 (clone TIA1, ready to use, Biocare, Concord, CA), CK7 (clone OVTL, Dako, Carpinteria, CA) and PD-L1 (clone E1L3N, 1:200 Cell Signaling, Danvers, MA). For antigen retrieval, the sections were pre-treated at low pH for PD-L1 and CD8, CD4, CD20, CD56 and CD68. PD-L1 antibody and membranous immunoreactivity was assessed semi-quantitatively in tumor cells as follows: <1% staining was considered negative, staining in 1–50% of tumor cells was scored as focal, and >50% staining was scored as diffusely positive.
+ Open protocol
+ Expand
7

Immunohistochemical Profiling of Lymphoid Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue sections were subjected to the same deparaffinization, antigen retrieval, and blocking protocol mentioned above. The lymph node and spleen sections were stained with primary antibodies for CD3 (clone 2GV6, Ventana), CD4 (Clone SP35, Ventana), CD8 (clone 144B, Agilent), CD20 (Clone L26, Agilent), and TIA-1 (clone TIA1, Biocare).
+ Open protocol
+ Expand
8

Immunohistochemical and FISH Analysis of DLBCL

Check if the same lab product or an alternative is used in the 5 most similar protocols
IHC was prospectively performed on the routine diagnostic basis using representative whole formalin-fixed paraffin-embedded (FFPE) tissue sections and antibodies against CD3 (clone 2GV6; Ventana Medical Systems, Tucson, AZ, USA), CD20 (clone L26; DAKO, Carpinteria, CA, USA), BCL2 (clone 124; DAKO, Carpinteria, CA, USA), BCL6 (clone LN22; Novocastra, Newcastle, UK), CD10 (clone 56C6; Novocastra), MUM1 (clone Ma695; Novocastra), MYC (clone EP121; Cell Marque, Rocklin, CA, USA), and Ki-67 (clone MIB-1; DAKO). Staining was performed using a Ventana Benchmark XT (Ventana Medical Systems) or a Bond-Max autostainer (Leica Microsystems, Melbourne, Australia). COO was determined using the IHC-based Hans algorithm as previously described [29 (link)]. DE status was defined as the co-expression of MYC (in ≥40% of tumor cells) and BCL2 (in ≥70% of tumor cells) as previously described [12 (link)]. TMA was constructed using the FFPE tissue blocks from 50 selected cases with DLBCL, and we performed MYC, BCL2, BCL6 FISH on the TMA. FISH was performed using Vysis LSI BCL2 Dual Color Break Apart Rearrangement Probe (Vysis, Downers Grove, IL, USA), Vysis LSI BCL6 Dual Color Break Apart Rearrangement Probe (Vysis), and Vysis LSI MYC Dual Color Break Apart Rearrangement Probe (Vysis)).
+ Open protocol
+ Expand
9

Immunohistochemical Profiling of B-cell Lymphomas

Check if the same lab product or an alternative is used in the 5 most similar protocols
IHC was performed using antibodies against CD3 (clone 2GV6; Ventana Medical Systems, Tucson, AZ), CD20 (clone L26; DAKO, Carpinteria, CA), BCL2 (clone 124; DAKO), BCL6 (clone LN22; Novocastra, Newcastle, UK), CD10 (clone 56C6; Novocastra), MUM1 (clone Ma695; Novocastra), MYC (clone EP121; Cell Marque, Rocklin, CA), Ki-67 (MIB-1; Ventana Medical Systems), PD-1 (clone MRQ-22; Cell Marque), IgD (clone DRN1C; Novocastra), and FOXP1 (clone SP133; Cell Marque) on representative whole FFPE tissue sections. Epstein-Barr virus in situ hybridization was performed using the Bond Ready-to-Use ISH EBER probe (Leica Biosystems, Newcastle, UK) or the INFORM EBER probe (Ventana Medical Systems). Immunostaining was performed using Ventana Benchmark XT (Ventana Medical Systems) or Bond-Max autostainer (Leica Microsystems, Melbourne, Australia) according to the manufacturer’s protocol.
B-cell monoclonality was detected using the IdentiClone IGH Gene Clonality Assay (Invivoscribe Technologies Inc., San Diego, CA).
+ Open protocol
+ Expand
10

Automated Multiplex Immunohistochemistry for Tissue Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining was performed on 2 µm paraffin sections with an automated IHC staining system (Ventana BenchMark ULTRA, Ventana Medical Systems, Italy). Sequential double IHC was performed on Ventana BenchMark ULTRA, using a ultraView Universal DAB detection Kit as the first stain and ultraView Universal Alkaline phosphatase Red detection kit as the second stain. Heat-induced epitope retrieval pre-treatment was performed using CC1 buffer (standard CC1, Roche Ventana) by boiling for 36 min for both CD31 and CD3 and for 64 min for RORγt. Afterwards, slides were incubated with primary antibodies: CD31 antibody (clone JC70, Cell Marque, dilution 1:20) for 16 min at 37°C or CD3 (clone 2GV6, Ventana, dilution 1:20) for 44 min at 37°C and RORγt (clone 6F3.1, Millipore, dilution 1:20) for 36 min at 37°C. CD31 and CD3 were visualized with DAB chromogen, and RORγt was visualized with Fast Red chromogen.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!